We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » UK Industry and Regulators Spar Over Drug Development Costs
UK Industry and Regulators Spar Over Drug Development Costs
September 3, 2013
British regulators are questioning whether the cost of drug development is unnecessarily high in response to editorials in The Times of London that warn of a UK manufacturing exodus due to a burdensome business environment.